CEoT Symposium: Prospera dd-cfDNA upheld as a leading indicator for kidney transplant rejection
Follow
Check out the Natera sponsored Symposium, which took place at CEoT 2024. "New Trifecta Study Publication: Prospera ddcfDNA upheld as a leading indicator for kidney transplant rejection"
This was not an official function of the CEoT meeting and is not endorsed by the AST